Reduced Dietary Omega-6 to Omega-3 Fatty Acid Ratio and 12/15-Lipoxygenase Deficiency Are Protective against Chronic High Fat Diet-Induced Steatohepatitis

Obesity is associated with metabolic perturbations including liver and adipose tissue inflammation, insulin resistance, and type 2 diabetes. Omega-6 fatty acids (ω6) promote and omega-3 fatty acids (ω3) reduce inflammation as they can be metabolized to pro- and anti-inflammatory eicosanoids, respectively. 12/15-lipoxygenase (12/15-LO) enzymatically produces some of these metabolites and is induced by high fat (HF) diet. We investigated the effects of altering dietary ω6/ω3 ratio and 12/15-LO deficiency on HF diet-induced tissue inflammation and insulin resistance. We examined how these conditions affect circulating concentrations of oxidized metabolites of ω6 arachidonic and linoleic acids and innate and adaptive immune system activity in the liver. For 15 weeks, wild-type (WT) mice were fed either a soybean oil-enriched HF diet with high dietary ω6/ω3 ratio (11∶1, HFH), similar to Western-style diet, or a fat Kcal-matched, fish oil-enriched HF diet with a low dietary ω6/ω3 ratio of 2.7∶1 (HFL). Importantly, the total saturated, monounsaturated and polyunsaturated fat content was matched in the two HF diets, which is unlike most published fish oil studies in mice. Despite modestly increased food intake, WT mice fed HFL were protected from HFH-diet induced steatohepatitis, evidenced by decreased hepatic mRNA expression of pro-inflammatory genes and genes involved in lymphocyte homing, and reduced deposition of hepatic triglyceride. Furthermore, oxidized metabolites of ω6 arachidonic acid were decreased in the plasma of WT HFL compared to WT HFH-fed mice. 12/15-LO knockout (KO) mice were also protected from HFH-induced fatty liver and elevated mRNA markers of inflammation and lymphocyte homing. 12/15-LOKO mice were protected from HFH-induced insulin resistance but reducing dietary ω6/ω3 ratio in WT mice did not ameliorate insulin resistance or adipose tissue inflammation. In conclusion, lowering dietary ω6/ω3 ratio in HF diet significantly reduces steatohepatitis.

[1]  W. Wahli,et al.  The peroxisomal enzyme L-PBE is required to prevent the dietary toxicity of medium-chain fatty acids. , 2013, Cell reports.

[2]  R. Bataller,et al.  Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis , 2013, Gut.

[3]  P. Hollman,et al.  Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice , 2013, PloS one.

[4]  Andrés Rosende,et al.  [Obesity and metabolic syndrome in children and adolescents]. , 2013, Medicina.

[5]  L. Videla,et al.  N-3 Long-Chain Polyunsaturated Fatty Acid Supplementation Significantly Reduces Liver Oxidative Stress in High Fat Induced Steatosis , 2012, PloS one.

[6]  K. Verhoeckx,et al.  Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids , 2012, PloS one.

[7]  S. Tangye,et al.  Inflammatory Mechanisms in Obesity , 2013 .

[8]  G. Bedogni,et al.  Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial , 2011, Archives of Disease in Childhood.

[9]  V. Arroyo,et al.  Disruption of the 12/15‐lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease , 2010, Hepatology.

[10]  Dorothy D. Sears,et al.  Osteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in Mice , 2010, PloS one.

[11]  S. Hazen,et al.  Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[S] , 2010, Journal of Lipid Research.

[12]  S. Watkins,et al.  GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2010, Cell.

[13]  E. Fisher,et al.  Fish Oil for the Treatment of Cardiovascular Disease , 2010, Cardiology in review.

[14]  C. Byrne.  Fatty liver: role of inflammation and fatty acid nutrition. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[15]  C. Glass,et al.  Macrophages, inflammation, and insulin resistance. , 2010, Annual review of physiology.

[16]  Chun-Ka Wong,et al.  Fish‐oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[17]  Dorothy D. Sears,et al.  12/15-Lipoxygenase Is Required for the Early Onset of High Fat Diet-Induced Adipose Tissue Inflammation and Insulin Resistance in Mice , 2009, PloS one.

[18]  S. Keller,et al.  12/15‐Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3‐L1 Adipocytes , 2009, Obesity.

[19]  V. Arroyo,et al.  Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  P. Flachs,et al.  Prevention and Reversal of Obesity and Glucose Intolerance in Mice by DHA Derivatives , 2009, Obesity.

[21]  P. Flachs,et al.  n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet , 2009, Diabetologia.

[22]  D. Kelley,et al.  Prevention of insulin resistance by n-3 polyunsaturated fatty acids , 2009, Current opinion in clinical nutrition and metabolic care.

[23]  Hai-ning Wang,et al.  Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. , 2008, World journal of gastroenterology.

[24]  G. Gerken,et al.  Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR , 2008, BMC Cancer.

[25]  Meng Chen,et al.  12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. , 2008, American journal of physiology. Endocrinology and metabolism.

[26]  J. Olefsky,et al.  Insulin sensitivity: modulation by nutrients and inflammation. , 2008, The Journal of clinical investigation.

[27]  T. Naka,et al.  SOCS1 Regulates CCR7 Expression and Migration of CD4+ T Cells into Peripheral Tissues1 , 2008, The Journal of Immunology.

[28]  A. Simopoulos,et al.  The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases , 2008, Experimental biology and medicine.

[29]  G. Schmitz,et al.  The opposing effects of n-3 and n-6 fatty acids. , 2008, Progress in lipid research.

[30]  A. O’Garra,et al.  TH1 cells control themselves by producing interleukin-10 , 2007, Nature Reviews Immunology.

[31]  P. Angulo,et al.  Obesity and nonalcoholic fatty liver disease. , 2007, Nutrition reviews.

[32]  Y. Matsuzawa.  The metabolic syndrome and adipocytokines , 2006, Expert review of clinical immunology.

[33]  M. Voiculescu,et al.  The role of cytokines in non-alcoholic steatohepatitis. A review. , 2006, Journal of gastrointestinal and liver diseases : JGLD.

[34]  G. Svegliati-Baroni,et al.  A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. , 2006, The American journal of pathology.

[35]  J. Schölmerich,et al.  Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. , 2006, Journal of molecular endocrinology.

[36]  P. Calder,et al.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[37]  M. Gillum,et al.  Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. , 2006, Diabetes.

[38]  B. Staels.  When the Clock stops ticking, metabolic syndrome explodes , 2006, Nature Medicine.

[39]  M. Schwartz,et al.  12/15-Lipoxygenase Regulates Intercellular Adhesion Molecule-1 Expression and Monocyte Adhesion to Endothelium Through Activation of RhoA and Nuclear Factor-&kgr;B , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[40]  D. S. Worrall,et al.  Toll-Like Receptor 4–Dependent and –Independent Cytokine Secretion Induced by Minimally Oxidized Low-Density Lipoprotein in Macrophages , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[41]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[42]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[43]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[44]  J. Witztum,et al.  Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells* , 2003, The Journal of Biological Chemistry.

[45]  R. Natarajan,et al.  Signaling Mechanisms of Nuclear Factor-&kgr;B-Mediated Activation of Inflammatory Genes by 13-Hydroperoxyoctadecadienoic Acid in Cultured Vascular Smooth Muscle Cells , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[46]  H. Okamura,et al.  IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner , 2000, Gut.

[47]  A. Diehl,et al.  Altered hepatic lymphocyte subpopulations in obesity‐related murine fatty livers: Potential mechanism for sensitization to liver damage , 2000, Hepatology.

[48]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[49]  G. Shulman,et al.  Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. , 1999, Diabetes.

[50]  O. Ezaki,et al.  High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. , 1996, Metabolism: clinical and experimental.

[51]  T. Drake,et al.  Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.